← Screener

ISRGIntuitive Surgical

Health care · Medical Devices · Nasdaq

Compare with peers → Embed

Filings with the SEC since Feb 8, 2019

1,018 filings, 21 in the last 30 days

SEC filing index

Latest annual reportOpen ↗

Feb 3, 2026

10-K, period to Dec 31, 2025

Latest quarterly reportOpen ↗

Oct 21, 2026

10-Q, period to Sep 30, 2026

Latest current reportOpen ↗

Nov 2, 2026

8-K: Director or officer change, Regulation FD disclosure

Filed in the last 30 days

of 1,018 in all

Timeline

Every filing on one line

1 yr 2 yr 3 yr

Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)

20252026

All 27 events

Nov 2, 20268-K Director or officer change, Regulation FD disclosure 8-K items 5.02, 7.01
Oct 21, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026
Oct 20, 20268-K Quarterly results 8-K item 2.02
Jul 27, 20268-K Bylaws or fiscal year changed 8-K item 5.03
Jul 21, 202610-Q Quarterly report (10-Q) period ended Jun 30, 2026
Jul 16, 20268-K Quarterly results 8-K item 2.02
May 28, 20268-K Director or officer change 8-K item 5.02
May 4, 20268-K Director or officer change, Shareholder vote results, Regulation FD disclosure 8-K items 5.02, 5.07, 7.01
Apr 22, 202610-Q Quarterly report (10-Q) period ended Mar 31, 2026
Apr 21, 20268-K Quarterly results 8-K item 2.02
Mar 2, 20268-K Other events 8-K item 8.01
Feb 3, 202610-K Annual report (10-K) period ended Dec 31, 2025
Jan 22, 20268-K Quarterly results 8-K item 2.02
Jan 14, 20268-K Quarterly results 8-K item 2.02
Dec 18, 20258-K Director or officer change 8-K item 5.02
Oct 22, 202510-Q Quarterly report (10-Q) period ended Sep 30, 2025
Oct 21, 20258-K Quarterly results 8-K item 2.02
Jul 23, 202510-Q Quarterly report (10-Q) period ended Jun 30, 2025
Jul 22, 20258-K Quarterly results 8-K item 2.02
May 15, 20258-K Director or officer change, Regulation FD disclosure 8-K items 5.02, 7.01
May 5, 20258-K Director or officer change, Shareholder vote results, Regulation FD disclosure 8-K items 5.02, 5.07, 7.01
Apr 23, 202510-Q Quarterly report (10-Q) period ended Mar 31, 2025
Apr 22, 20258-K Quarterly results 8-K item 2.02
Jan 31, 202510-K Annual report (10-K) period ended Dec 31, 2024
Jan 23, 20258-K Quarterly results, Other events 8-K items 2.02, 8.01
Jan 15, 20258-K Quarterly results 8-K item 2.02
Jan 6, 20258-K Director or officer change 8-K item 5.02

From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).

Every filing

Newest first, by kind

Each form links to sec.gov

All 1018 Annual & quarterly 31 Current reports (8-K) 67 Insiders 859 Proxy & votes 18 Big owners (13D/13G) 22 Shares & debt offered 7 SEC letters 3 Other 11

Filed	Form	What it is	Period
Mar 13, 2026	DEFA14A	Extra proxy material		all files
Mar 13, 2026	DEF 14A	Proxy statement	Dec 31, 2025	all files
Mar 14, 2025	DEFA14A	Extra proxy material		all files
Mar 14, 2025	DEF 14A	Proxy statement	Dec 31, 2024	all files
Mar 8, 2024	DEFA14A	Extra proxy material		all files
Mar 8, 2024	DEF 14A	Proxy statement	Dec 31, 2023	all files
Mar 27, 2023	PX14A6G	Shareholder's proxy letter		all files
Mar 10, 2023	DEFA14A	Extra proxy material		all files
Mar 10, 2023	DEF 14A	Proxy statement		all files
Mar 9, 2022	DEF 14A	Proxy statement	Apr 28, 2022	all files
Aug 19, 2021	DEF 14A	Proxy statement	Aug 18, 2021	all files
Aug 5, 2021	PRE 14A		Aug 5, 2021	all files
Mar 10, 2021	DEFA14A	Extra proxy material		all files
Mar 10, 2021	DEF 14A	Proxy statement	Mar 10, 2021	all files
Mar 13, 2020	DEFA14A	Extra proxy material		all files
Mar 13, 2020	DEF 14A	Proxy statement	Apr 23, 2020	all files
Feb 27, 2020	PRE 14A		Dec 31, 2019	all files
Mar 8, 2019	DEF 14A	Proxy statement	Dec 31, 2018	all files

Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.

Next Earnings releases →